Sign in

CIK 0000310158

  • Large accelerated filer

Merck & Co., Inc.

Sign in to watch
Ticker
MRK
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NJ
Entity type
Operating
EIN
221918501
Phone
+1 908-740-4000
Business address
126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
Former names
Merck & Co. Inc., SCHERING PLOUGH CORP
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Exercise or conversion SVP Fin. - Global Controller acquired 383 shares (option exercise)
  4. 4 Exercise or conversion EVP & Pres. MMD acquired 552 shares (option exercise)
  5. 3/A Insider 3/A
  6. 3 Insider Initial Statement of Ownership
  7. 4 Exercise or conversion EVP, Access, Policy & Comms acquired 1,967 shares (option exercise)
  8. 4 Exercise or conversion Exe V-P & Pres. MMD acquired 2,597 shares (option exercise)
  9. 4 Exercise or conversion EVP&Pres, Merck Animal Heallth acquired 2,518 shares (option exercise)
  10. 4 Exercise or conversion EVP,Chief Info&Digital Officer acquired 1,377 shares (option exercise)
  11. 4 Exercise or conversion SVP Fin. - Global Controller acquired 1,408 shares (option exercise)
  12. 4 Exercise or conversion Executive VP & President, MRL acquired 4,722 shares (option exercise)
  13. 4 Exercise or conversion EVP, General Counsel acquired 2,951 shares (option exercise)
  14. 4 Exercise or conversion EVP, Chief HR Officer acquired 13,435 shares (option exercise)
  15. 4 Exercise or conversion EVP & CFO acquired 3,935 shares (option exercise)
  16. 4 Exercise or conversion Chairman, CEO & President acquired 13,300 shares (option exercise)
  17. 4 Exercise or conversion EVP, Oncology & Int?l acquired 1,377 shares (option exercise)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 3 of 99 · 1,973 filings